Your browser doesn't support javascript.
Canakinumab in a subgroup of patients with COVID-19.
Ucciferri, Claudio; Auricchio, Antonio; Di Nicola, Marta; Potere, Nicola; Abbate, Antonio; Cipollone, Francesco; Vecchiet, Jacopo; Falasca, Katia.
  • Ucciferri C; Clinic of Infectious Diseases, Department of Medicine and Science of Aging, G. d'Annunzio University of Chieti-Pescara, Chieti 66100, Italy.
  • Auricchio A; Department of Medicine and Health Sciences, University of Molise, Campobasso, Italy.
  • Di Nicola M; Clinic of Infectious Diseases, Department of Medicine and Science of Aging, G. d'Annunzio University of Chieti-Pescara, Chieti 66100, Italy.
  • Potere N; Laboratory of Biostatistics, Department of Medical, Oral and Biotechnological Sciences, G. d'Annunzio University of Chieti-Pescara, Chieti 66100, Italy.
  • Abbate A; VCU Health Pauley Heart Center, Virginia Commonwealth University, Richmond, VA, USA.
  • Cipollone F; VCU Health Pauley Heart Center, Virginia Commonwealth University, Richmond, VA, USA.
  • Vecchiet J; Clinica Medica Institute, European Center of Excellence on Atherosclerosis, Hypertension and Dyslipidemia, G. d'Annunzio University of Chieti-Pescara, Chieti 66100, Italy.
  • Falasca K; Clinic of Infectious Diseases, Department of Medicine and Science of Aging, G. d'Annunzio University of Chieti-Pescara, Chieti 66100, Italy.
Lancet Rheumatol ; 2(8): e457-ee458, 2020 Aug.
Article in English | MEDLINE | ID: covidwho-526896

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Lancet Rheumatol Year: 2020 Document Type: Article Affiliation country: S2665-9913(20)30167-3

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Lancet Rheumatol Year: 2020 Document Type: Article Affiliation country: S2665-9913(20)30167-3